Organon & Co. (OGN) — Analysis Summary
Organon & Co. (OGN) has a market cap of $3.53B with year-over-year revenue growth of -2.9%. Net margin stands at 3.0%. The stock trades at a P/E ratio of 14.3.
Key Takeaways
- Revenue changed -2.9% year-over-year
- Net margin of 3.0%
- P/E ratio of 14.3
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, OGN posted revenue growth of -2.9% and trades at a P/E of 14.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.